Synoplex
Loading...Synoplex Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
Not for use in humans. Keep out of the reach of children. In case of skin, eye contact, or ingestion, flush affected area with water. If inhalation occurs and breathing becomes difficult, move to fresh air, and contact a physician.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
For topical application on animals in the family Elephantidae and Rhinocerotidae for treatment of foot and dermal lesions infected with aerobic or facultative anaerobic Gram-positive and/or Gram-negative bacteria; and for treatment of sterile chronic foot and dermal lesions.
FOR USE IN ANIMALS IN THE FAMILY ELEPHANTIDAE AND RHINOCEROTIDAE ONLY; THIS PRODUCT IS NOT TO BE USED IN ANIMALS INTENDED FOR USE AS FOOD FOR HUMANS OR OTHER ANIMALS.
History
There is currently no drug history available for this drug.
Other Information
Derived from chitin obtained from Arctic shrimp shells, Synoplex® has an approximate molecular weight of 20 to 100 kDa. Each gram of Synoplex® contains 1 gram of poly (acetyl, arginyl) glucosamine. Synoplex® is supplied as a dry soluble powder, that is rehydrated with sterile water prior to use. Synoplex® acts on the bacterial membrane causing aggregation of bacteria and pore formation leading to reduction of viable bacteria and prevention of biofilm formation.
Sources
Synoplex Manufacturers
-
Synedgen, Inc.
![Synoplex (Poly (Acetyl, Arginyl) Glucosamine) Powder, For Solution [Synedgen, Inc.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Synoplex | Synedgen, Inc.
Synoplex® is supplied as a dry soluble powder, needing to be rehydrated with sterile water prior to use. Wear gloves during handling and use of Synoplex®. Determine the amount of Synoplex® powder needed to achieve the desired concentration for the intended use. Dissolve Synoplex® in a known volume of sterile water and mix well. Before applying rinse treatment, ensure that the lesion is properly debrided.
A general dose of Synoplex® for infected wounds is 500μg/mL and for non-infected wounds is 200μg/mL in a volume sufficient to moisten the affected area. The frequency of application should be 1-2 times per day until the lesion is resolved. Synoplex® should always be used in conjunction with good wound care consisting of initial debridement to remove all necrotic and/or infected tissue.
The possible doses are calculated below.
Synoplex Powder Synoplex Dosage Amount of Sterile Water Example: 1) 1g X 200 µg/mL = 5L Example: 2) 1g X 500 µg/mL = 2L
Login To Your Free Account